Affinity DataIC50: 1nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 4.10nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 10nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 11nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 11nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 11nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 12nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 12nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 12nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 14nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 21nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 21nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 27nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 28nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 29nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 35nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 40nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 43nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 52nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 74nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 76nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Incheon University Industry Academic Cooperation Foundation
US Patent
Incheon University Industry Academic Cooperation Foundation
US Patent
Affinity DataIC50: 82nMAssay Description:The inhibitory activities of the compounds of the present invention against VEGFR-2 tyrosine kinase were analyzed using ADP-Glo™ kinase assay kit com...More data for this Ligand-Target Pair